Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shenghua Shi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Computational Chemistry|May 22, 2003
An extensible and systematic force field, ESFF, for molecular modeling of organic, inorganic, and organometallic systemsShenghua Shi, Lisa Yan, Yang Yang, et al.
Journal of Computer-Aided Molecular Design|July 14, 2009
Combinatorial library-based design with Basis ProductsJoe Zhongxiang Zhou, Shenghua Shi, Jim Na, et al.
Scientific Reports|April 17, 2025
Relationship between smoking status and ulcerative colitis: a meta-analysis based on a case-control studyYong Mi, Yue Tan, Yangyang Yu, et al.
Hepatology International|July 26, 2018
Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinantHua Li, Qilu She, Yu Liu, et al.
Carbohydrate Polymers|November 7, 2017
Design of injectable agar-based composite hydrogel for multi-mode tumor therapyChenyao Wu, Jiulong Zhao, Fei Hu, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Human glucagon receptor antagonists based on alkylidene hydrazidesAnthony Ling, Michael Plewe, Javier Gonzalez, et al.
Journal of Medicinal Chemistry|December 13, 2002
Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazidePeter Madsen, Anthony Ling, Michael Plewe, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymesRobert J Ardecky, Ekaterina V Bobkova, Tina Kiffer-Moreira, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentDean R Artis, Jack J Lin, Chao Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Computational Chemistry|May 22, 2003
An extensible and systematic force field, ESFF, for molecular modeling of organic, inorganic, and organometallic systemsShenghua Shi, Lisa Yan, Yang Yang, et al.
Journal of Computer-Aided Molecular Design|July 14, 2009
Combinatorial library-based design with Basis ProductsJoe Zhongxiang Zhou, Shenghua Shi, Jim Na, et al.
Scientific Reports|April 17, 2025
Relationship between smoking status and ulcerative colitis: a meta-analysis based on a case-control studyYong Mi, Yue Tan, Yangyang Yu, et al.
Hepatology International|July 26, 2018
Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinantHua Li, Qilu She, Yu Liu, et al.
Carbohydrate Polymers|November 7, 2017
Design of injectable agar-based composite hydrogel for multi-mode tumor therapyChenyao Wu, Jiulong Zhao, Fei Hu, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Human glucagon receptor antagonists based on alkylidene hydrazidesAnthony Ling, Michael Plewe, Javier Gonzalez, et al.
Journal of Medicinal Chemistry|December 13, 2002
Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazidePeter Madsen, Anthony Ling, Michael Plewe, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymesRobert J Ardecky, Ekaterina V Bobkova, Tina Kiffer-Moreira, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentDean R Artis, Jack J Lin, Chao Zhang, et al.
Pageof 1